Home › Funds › Concentric Capital Strategies, LP › BIO

Concentric Capital Strategies, LP position in BIO

BIO RAD LABS INC CL A · Industrials

Concentric Capital Strategies, LP reported holding 23,692 shares of BIO (BIO RAD LABS INC CL A) in its Q2 2026 13F filing — a position valued at US$7.0M, representing 0.39% of its reported portfolio and ranking #45 among its reported holdings. Concentric Capital Strategies, LP first reported this position in Q2 2026.

Latest position (Q2 2026)23.69K sh
Reported value held$6.96M
Portfolio Weight0.39%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Concentric Capital Strategies, LP's BIO position evolved

Concentric Capital Strategies, LP first disclosed a stake in BIO in Q2 2026 at 23,692 shares (US$7.0M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 23.69K $6.96M New

About BIO and 13F data

BIO (BIO RAD LABS INC CL A) is a Industrials company. 23 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$765.2M), ARIEL INVESTMENTS, LLC (US$239.8M), First Pacific Advisors, LP (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIO

All BIO fund holders →

FAQ

How long has Concentric Capital Strategies, LP held BIO?

Concentric Capital Strategies, LP has disclosed BIO holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Concentric Capital Strategies, LP's current position in BIO?

As of Q2 2026, Concentric Capital Strategies, LP holds 23.69K shares of BIO (BIO RAD LABS INC CL A), valued at $6.96M, representing 0.39% of its reported portfolio and ranking #45.

Has Concentric Capital Strategies, LP been buying or selling BIO?

In the latest 13F filing (Q2 2026), Concentric Capital Strategies, LP newly opened its position in BIO.

Which other funds hold BIO?

Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, First Pacific Advisors, LP, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.